Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers

References

• ZhouZTZhouFXWeiQPhase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancerCancer Chemother Pharmacol2011 [Epub ahead of print]
   Web of Science ®Google Scholar
• LingYYangYLuNEndostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cellsBiochem Biophys Res Commun2007361798417644065
   PubMed Web of Science ®Google Scholar
• ZhuoWLuoCWangXSongXFuYLuoYEndostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cellsJ Pathol201022224926020814900
   PubMed Web of Science ®Google Scholar
• HanBXiuQWangHA multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of paclitaxel-carboplatin alone or with endostar for advanced non-small cell lung cancerJ Thorac Oncol201161104110921532504
   PubMed Web of Science ®Google Scholar
• KiskerOBeckerCMProxDContinuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor modelCancer Res2001617669767411606410
   PubMed Web of Science ®Google Scholar
• XuFMaQShaHOptimizing drug delivery for enhancing therapeutic efficacy of recombinant human endostatin in cancer treatmentCrit Rev Ther Drug Carrier Syst20072444549218197781
   PubMed Web of Science ®Google Scholar
• KuroiwaMTakeuchiTLeeJHContinuous versus intermittent administration of human endostatin in xenografted human neuroblastomaJ Pediatr Surg2003381499150514577075
   PubMed Web of Science ®Google Scholar
• TongYZhongKTianHCharacterization of a monoPEG20000-EndostarInt J Biol Macromol20104633133620122957
   PubMed Web of Science ®Google Scholar
• SongHFLiuXWZhangHNPharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeysActa Pharmacol Sin20052612412815659125
   PubMed Web of Science ®Google Scholar
• JiangLPZouCYuanXLuoWWenYChenYN-terminal modification increases the stability of the recombinant human endostatin in vitroBiotechnol Appl Biochem20095411312019527221
   PubMed Web of Science ®Google Scholar
• MengBLiLHuaSEffect of medium-chain triglycerides on the release behavior of Endostar encapsulated PLGA microspheresInt J Pharm201039713614320655370
   PubMed Web of Science ®Google Scholar
• HuSZhangYEndostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluationInt J Nanomedicine201051039104821170352
   PubMed Web of Science ®Google Scholar
• MuthuMNanoparticles based on PLGA and its co-polymer: an overviewAsian Journal of Pharmaceutics20093266273
   Google Scholar
• TanMLChoongPFDassCRRecent developments in liposomes, microparticles and nanoparticles for protein and peptide drug deliveryPeptides20103118419319819278
   PubMed Web of Science ®Google Scholar
• WangMThanouMTargeting nanoparticles to cancerPharmacol Res201062909920380880
   PubMed Web of Science ®Google Scholar
• LiSDHuangLNanoparticles evading the reticuloendothelial system: role of the supported bilayerBiochim Biophys Acta200917882259226619595666
   PubMed Web of Science ®Google Scholar
• CohenSYoshiokaTLucarelliMHwangLHLangerRControlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheresPharm Res199187137202062800
   PubMed Web of Science ®Google Scholar
• RoyASinghMSUpadhyayPKBhaskarSCombined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approachMol Pharm2010 [Epub ahead of print]
   Web of Science ®Google Scholar
• MukherjeeBSantraKPattnaikGGhoshSPreparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymersInt J Nanomedicine2008348749619337417
   PubMed Web of Science ®Google Scholar
• GrefRQuellecPSanchezACalvoPDellacherieEAlonsoMJDevelopment and characterization of CyA-loaded poly(lactic acid)- poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriersEur J Pharm Biopharm20015111111811226817
   PubMed Web of Science ®Google Scholar
• ZwickMMThe blue complexes of iodine with poly(vinyl alcohol) and amyloseJ Polym Sci A11966416421644
   Web of Science ®Google Scholar
• WuJWuLXuXMicrospheres made by w/o/o emulsion method with reduced initial burst for long-term delivery of endostar, a novel recombinant human endostatinJ Pharm Sci2009982051205818823006
   PubMed Web of Science ®Google Scholar
• ThomasJPArzoomanianRZAlbertiDPhase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumorsJ Clin Oncol20032122323112525513
   PubMed Web of Science ®Google Scholar
• WuJDingDRenGXuXYinXHuYSustained delivery of endostatin improves the efficacy of therapy in Lewis lung cancer modelJ Control Release2009134919719084038
   PubMed Web of Science ®Google Scholar
• PanyamJDaliMMSahooSKPolymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticlesJ Control Release20039217318714499195
   PubMed Web of Science ®Google Scholar
• JainRAThe manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devicesBiomaterials2000212475249011055295
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol2007275176018654426
   PubMed Web of Science ®Google Scholar
• WangMDShinDMSimonsJWNieSNanotechnology for targeted cancer therapyExpert Rev Anticancer Ther2007783383717555393
   PubMed Web of Science ®Google Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov2010961562720616808
   PubMed Web of Science ®Google Scholar
• MoghimiSMSzebeniJStealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding propertiesProg Lipid Res20034246347814559067
   PubMed Web of Science ®Google Scholar
• TracyMAWardKLFirouzabadianLFactors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitroBiomaterials1999201057106210378806
   PubMed Web of Science ®Google Scholar
• Ingvast-LarssonCHolgerssonABondessonULagerstedtASOlssonKClinical pharmacology of methadone in dogsVet Anaesth Analg201037485620017819
   PubMed Web of Science ®Google Scholar
• KapitzaCZdravkovicMZijlstraESegelSHeiseTFlintAEffect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutideJ Clin Pharmacol20115195195520671294
   PubMed Web of Science ®Google Scholar
• JeongYIKangMKSunHSAll-trans-retinoic acid release from core-shell type nanoparticles of poly(epsilon-caprolactone)/poly(ethylene glycol) diblock copolymerInt J Pharm20042739510715010134
   PubMed Web of Science ®Google Scholar
• ZhangXPanSRHuHMPoly(ethylene glycol)-block-polyethylenimine copolymers as carriers for gene delivery: effects of PEG molecular weight and PEGylation degreeJ Biomed Mater Res A20088479580417635020
   PubMed Web of Science ®Google Scholar
• HobbsSKMonskyWLYuanFRegulation of transport pathways in tumor vessels: role of tumor type and microenvironmentProc Natl Acad Sci U S A199895460746129539785
   PubMed Web of Science ®Google Scholar